The endothelium and inflammation

被引:108
作者
Trepels, Thomas [1 ]
Zeiher, Andreas. M. [1 ]
Fichtlscherer, Stephan [1 ]
机构
[1] Univ Frankfurt, Div Cardiol, Dept Internal Med 3, D-60590 Frankfurt, Germany
来源
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH | 2006年 / 13卷 / 06期
关键词
anti-inflammation; biomarkers; endothelial function; endothelium; inflammation; nitric oxide;
D O I
10.1080/10623320601061862
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The vascular endothelium contributes to and is affected by inflammatory processes. Disturbance of the endothelium's morphologic and functional integrity in response to mechanical, immunologic, and chemical injuries reflects the first step in the pathophysiological cascade of atherosclerotic disorders. At the site of an endothelial injury, invading inflammatory cells producing numerous proinflammatory factors promote and amplify both local and systemic inflammation. These early changes on a cellular and subcellular level that precede the clinical manifestation of atherosclerosis are associated with loss of profound physiological functions of the endothelium. One pivotal function of the endothelium is nitric oxide-mediated regulation of vessel tone and blood flow according to the local requirements. The assessment of nitric oxide-mediated endothelial function by different methods revealed a close relation between inflammatory activation and endothelial dysfunction in healthy volunteers, patients at risk, and patients with established cardiovascular disease. Moreover, anti-inflammatory therapeutic interventions do not only have a positive impact on disease progression, but also on endothelial function, thus further providing an indirect line of evidence linking inflammation with endothelial dysfunction.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 53 条
[1]  
Bhagat K, 1996, CARDIOVASC RES, V32, P822
[2]   Endothelial dysfunction - A marker of atherosclerotic risk [J].
Bonetti, PO ;
Lerman, LO ;
Lerman, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) :168-175
[3]   Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden [J].
Brevetti, G ;
Silvestro, A ;
Di Giacomo, S ;
Bucur, R ;
Di Donato, A ;
Schiano, V ;
Scopacasa, F .
JOURNAL OF VASCULAR SURGERY, 2003, 38 (02) :374-379
[4]  
Brevetti G, 2001, THROMB HAEMOSTASIS, V85, P63
[5]   EDHF:: bringing the concepts together [J].
Busse, R ;
Edwards, G ;
Félétou, M ;
Fleming, I ;
Vanhoutte, PM ;
Weston, AH .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (08) :374-380
[6]   Peroxisome proliferator-activated receptor-γ activation with pioglitazone improves endothelium-dependent dilation in nondiabetic patients with major cardiovascular risk factors [J].
Campia, U ;
Matuskey, LA ;
Panza, JA .
CIRCULATION, 2006, 113 (06) :867-875
[7]  
Cannon RO, 1998, CLIN CHEM, V44, P1809
[8]   Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease [J].
Cleland, SJ ;
Sattar, N ;
Petrie, JR ;
Forouhi, NG ;
Elliott, HL ;
Connell, JMC .
CLINICAL SCIENCE, 2000, 98 (05) :531-535
[9]   Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes - The Hoorn Study [J].
de Jager, J ;
Dekker, JM ;
Kooy, A ;
Kostense, PJ ;
Nijpels, G ;
Heine, RJ ;
Bouter, LM ;
Stehouwer, CDA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) :1086-1093
[10]   A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment - A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [J].
Felmeden, DC ;
Blann, AD ;
Spencer, CGC ;
Beevers, DG ;
Lip, GYH .
BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (05) :425-431